OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S

OctoPlus announces the proposal to appoint Catherine Moukheibir to the Supervisory Board

OctoPlus N.V. announces that the Supervisory Board of the Company will nominate Catherine Moukheibir to be appointed as member of the Supervisory Board at the next General Meeting of Shareholders. This appointment will be for a period of four years. Catherine Moukheibir MA, MBA, age 52, was ... more

OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S

OctoPlus N.V.  announced that a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S. The undisclosed contract value will make a material contribution to OctoPlus' 2012 revenues. Further details on the compound and activities are not disclosed. more

OctoPlus wins drug development and manufacturing contract from Danish pharmaceutical company

OctoPlus N.V.  announced that a process development and manufacturing contract has been signed with a pharmaceutical company headquartered in Denmark. The undisclosed contract value will make a material contribution to OctoPlus' annual revenues.Under the contract terms, OctoPlus will perfor ... more

OctoPlus N.V.

OctoPlus is a drug delivery and drug development company that is globally renowned for its expertise and professionalism. Since our inception in 1995, we have established a successful track record and maintain partnerships with large and small biotech and pharma companies throughout the wor ... more

OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S

OctoPlus N.V.  announced that a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S. The undisclosed contract value will make a material contribution to OctoPlus' 2012 revenues. Further details on the compound and activities are not disclosed. more

Ferring Pharmaceuticals Acquires Cytokine PharmaSciences Inc.

Ferring Pharmaceuticals announced today that it has completed the purchase of Cytokine PharmaSciences Inc. (CPSI) and its UK subsidiary Controlled Therapeutics (Scotland) Ltd. (CTS), a global biopharmaceutical company with a particular focus in obstetrics.“This acquisition advances our visi ... more

Ferring Acquires LYSTEDA From Xanodyne Pharmaceuticals, Inc.

Ferring Pharmaceuticals announced an agreement that will expand its Women's Health product portfolio with the acquisition of the global rights to Xanodyne Pharmaceutical's LYSTEDA™ (tranexamic acid), a first-in-class, non-hormonal therapy indicated specifically for treatment of women with c ... more

Ferring Pharmaceuticals A/S

Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of infertility, obstetrics, urology, gastroenterology, endocrinology and osteoarthritis. The company’s research activities and products ... more

Ferring S.A.

Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of infertility, obstetrics, urology, gastroenterology, endocrinology and osteoarthritis. The company’s research activities and products ... more

Ferring S.A. de C.V.

Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of infertility, obstetrics, urology, gastroenterology, endocrinology and osteoarthritis. The company’s research activities and products ... more